Please login to the form below

Not currently logged in
Email:
Password:

Stoptober

This page shows the latest Stoptober news and features for those working in and with pharma, biotech and healthcare.

Oliver Group buys digital agency Dare

Oliver Group buys digital agency Dare

Its pharmaceutical and healthcare clients include Public Health England, for whom it created the anti-smoking campaign 'Stoptober' (pictured above), which has been created with 400, 000 attempts to quit smoking.

Latest news

  • The challenge of poor adherence in type 2 diabetes The challenge of poor adherence in type 2 diabetes

    Stoptober has had success in helping people to quit smoking via its app. ... Stoptober' uses key principles drawn from Behavioural Economics. 1. Behaviour is heavily influenced by others.

  • Smokefree brief for Two Birds One Stone

    NHS Wakefield District and South West Yorkshire Partnership NHS Foundation Trust are encouraging Wakefield's 80, 500 smokers to join Stoptober, the first mass quit attempt launched by the Department of

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Judith Moore joins Portland Health Judith Moore joins Portland Health

    From 2007 until 2013, Moore served as the Department of Health's public health media spokesperson, and managed a number of public health campaigns including Change4Life and Stoptober.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics